Small merger announcement

In accordance with Article 527-3 of the Commercial Act, the Company has signed a small-scale merger agreement with Genematrix Bio with the approval of the board of directors, and is therefore notified as follows.

 

- under -

 

1. Merger method: GeneMatrix Co., Ltd., a KOSDAQ-listed corporation, merged with GeneMatrix Bio Co., Ltd., an unlisted corporation. (Small-scale merger under Article 527-3 of the Commercial Act)

2. Merger ratio: 1.0000000: 0.1516601 / GeneMatrix Co., Ltd.: GeneMatrix Bio Co., Ltd.

3. Merger party companies

Surviving Company: GeneMatrix Co., Ltd.

Extinct Company: GeneMatrix Bio Co., Ltd.

4. Merger Date: October 1, 2019

5. The merger with GeneMatrix Bio Co., Ltd. is merged by resolution of the board of directors without obtaining approval from the general shareholders' meeting pursuant to Article 527-3 of the Commercial Act.

6. Guidance on the event of disagreement

-Event Procedure: Merger for shareholders who are listed on the shareholders' list as of July 31, 2019

Shareholders who disagree with the resolution of the board of directors must submit a notice to indicate their objection to the resolution of the board of directors.

-Submission period: August 01, 2019-August 14